Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5356)
All Articles published online
|
Jun 21, 2006 (publication date) through Feb 8, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Pierik M, Rutgeerts P, Vlietinck R, Vermeire S. Pharmacogenetics in inflammatory bowel disease. World J Gastroenterol 2006; 12(23): 3657-3667 [PMID: 16773681 DOI: 10.3748/wjg.v12.i23.3657] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v12/i23/3657.htm |
| Number | Citing Articles |
| 1 |
Ignacio Rego-Pérez, Mercedes Fernández-Moreno, Vanessa Carreira-García, Francisco J. Blanco. Gene polymorphisms and pharmacogenetics in rheumatoid arthritis. Reumatología Clínica (English Edition) 2009; 5(6): 268 doi: 10.1016/S2173-5743(09)70135-2
|
| 2 |
Ferenc Nagy, Tamás Molnár, Zoltán Szepes, Klaudia Farkas, Tibor Nyári, János Lonovics. Efficacy of 6-mercaptopurine treatment after azathioprine hypersensitivity in inflammatory bowel disease. World Journal of Gastroenterology 2008; 14(27): 4342-4346 doi: 10.3748/wjg.14.4342
|
| 3 |
MJ McDonnell, A Dhar. Azathioprine use in inflammatory bowel disease in South Durham – an insight into clinical practice. Journal of the Royal College of Physicians of Edinburgh 2009; 39(2): 100 doi: 10.1177/1478271520093902025
|
| 4 |
Trilokraj Tejasvi, Philip E. Stuart, Vinod Chandran, John J. Voorhees, Dafna D. Gladman, Proton Rahman, James T. Elder, Rajan P. Nair. TNFAIP3 Gene Polymorphisms Are Associated with Response to TNF Blockade in Psoriasis. Journal of Investigative Dermatology 2012; 132(3): 593 doi: 10.1038/jid.2011.376
|
| 5 |
Kalpesh K. Patel, Mark W. Babyatsky. Medical Education: A Key Partner in Realizing Personalized Medicine in Gastroenterology. Gastroenterology 2008; 134(3): 656 doi: 10.1053/j.gastro.2008.01.064
|
| 6 |
Cath Stansfeld. Making sense of metabolites, azathioprine and allopurinol in IBD. Gastrointestinal Nursing 2012; 10(2): 24 doi: 10.12968/gasn.2012.10.2.24
|
| 7 |
Rinse K Weersma, Cisca Wijmenga. Using genetic information for the identification, classification and treatment of Crohn’s disease: are we there yet?. Expert Review of Gastroenterology & Hepatology 2008; 2(6): 719 doi: 10.1586/17474124.2.6.719
|
| 8 |
Ignacio Rego-Pérez, Mercedes Fernández-Moreno, Vanessa Carreira-García, Francisco J. Blanco. Polimorfismos genéticos y farmacogenética en la artritis reumatoide. Reumatología Clínica 2009; 5(6): 268 doi: 10.1016/j.reuma.2008.12.001
|
| 9 |
Marc R Fournier, Julianne Klein, Gerald Y Minuk, Charles N Bernstein. Changes in Liver Biochemistry During Methotrexate Use for Inflammatory Bowel Disease. American Journal of Gastroenterology 2010; 105(7): 1620 doi: 10.1038/ajg.2010.21
|
| 10 |
Giovanni Latella, Claudio Fiocchi, Renzo Caprilli. Late-breaking news from the “4th International Meeting on Inflammatory Bowel Diseases” Capri, 2006. Inflammatory Bowel Diseases 2007; 13(8): 1031 doi: 10.1002/ibd.20127
|
| 11 |
Islam M. Ibrahim, Hanan S. Althagafy, Esraa K. Abd-alhameed, W.S. Al-Thubiani, Emad H.M. Hassanein. Promising hepatoprotective effects of lycopene in different liver diseases. Life Sciences 2022; 310: 121131 doi: 10.1016/j.lfs.2022.121131
|
| 12 |
Michael Eberhardson, Charlotte R. H. Hedin, Marie Carlson, Laura Tarnawski, Yaakov A. Levine, Peder S. Olofsson. Towards improved control of inflammatory bowel disease. Scandinavian Journal of Immunology 2019; 89(3) doi: 10.1111/sji.12745
|
| 13 |
C.R.H. Hedin, E. Sonkoly, M. Eberhardson, M. Ståhle. Inflammatory bowel disease and psoriasis: modernizing the multidisciplinary approach. Journal of Internal Medicine 2021; 290(2): 257 doi: 10.1111/joim.13282
|
| 14 |
Kalliopi P. Spyridopoulou, Niki L. Dimou, Stavros J. Hamodrakas, Pantelis G. Bagos. Methylene tetrahydrofolate reductase gene polymorphisms and their association with methotrexate toxicity. Pharmacogenetics and Genomics 2012; 22(2): 117 doi: 10.1097/FPC.0b013e32834ded2a
|
| 15 |
Ruta Steponaitiene, Juozas Kupcinskas, Santa Survilaite, Greta Varkalaite, Laimas Jonaitis, Gediminas Kiudelis, Goda Denapiene, Jonas Valantinas, Jurgita Skieceviciene, Limas Kupcinskas. TPMT and ITPA genetic variants in Lithuanian inflammatory bowel disease patients: Prevalence and azathioprine-related side effects. Advances in Medical Sciences 2016; 61(1): 135 doi: 10.1016/j.advms.2015.09.008
|
| 16 |
Rocio Sanchez, Emile Levy, Florin Costea, Daniel Sinnett. IL-10 and TNF-α promoter haplotypes are associated with childhood Crohn’s disease location. World Journal of Gastroenterology 2009; 15(30): 3776-3782 doi: 10.3748/wjg.15.3776
|
| 17 |
WANSHENG LAO, MEIYUN FANG, XIFEI YANG. FK506-binding protein 51 (FKBP5) gene polymorphism is not associated with glucocorticoid therapy outcome in patients with idiopathic thrombocytopenic purpura. Molecular Medicine Reports 2012; 6(4): 787 doi: 10.3892/mmr.2012.993
|
| 18 |
Javier P. Gisbert, Fernando Gomolln. Thiopurine-Induced Myelotoxicity in Patients With Inflammatory Bowel Disease: A Review. The American Journal of Gastroenterology 2008; 103(7): 1783 doi: 10.1111/j.1572-0241.2008.01848.x
|
| 19 |
Csilla Sipeky, Anita Maász, Gréta Tarlós, Katalin Komlósi, Éva Pollák, Béla Melegh. Importance of thiopurine s-methyltransferase gene test. Orvosi Hetilap 2012; 153(5): 191 doi: 10.1556/OH.2012.29289
|
| 20 |
Edna Efrati, Lior Adler, Norberto Krivoy, Eli Sprecher. Distribution of TPMT risk alleles for thioupurine toxicity in the Israeli population. European Journal of Clinical Pharmacology 2009; 65(3): 257 doi: 10.1007/s00228-008-0590-7
|
| 21 |
|
| 22 |
Patricia L Kozuch, Stephen B Hanauer. Treatment of inflammatory bowel disease: A review of medical therapy. World Journal of Gastroenterology 2008; 14(3): 354-377 doi: 10.3748/wjg.14.354
|
| 23 |
Matthew B. Stanton, Mark A. Solinski, Stephen B. Hanauer. Genetic polymorphisms impacting clinical pharmacology of drugs used to treat inflammatory bowel disease: a precursor to multi-omics approach to precision medicine. Expert Review of Clinical Immunology 2025; : 1 doi: 10.1080/1744666X.2025.2461584
|
| 24 |
Kalle Landerholm, Disa Kalman, Conny Wallon, Pär Myrelid. Immunomodulators: Friends or Enemies in Surgery for Crohn’s Disease?. Current Drug Targets 2019; 20(13): 1384 doi: 10.2174/1389450120666190617163919
|
| 25 |
Dana Duricova, Natalia Pedersen, Martin Lenicek, Christian Jakobsen, Milan Lukas, Vibeke Wewer, Pia Munkholm. The clinical implication of drug dependency in children and adults with inflammatory bowel disease: A review. Journal of Crohn's and Colitis 2011; 5(2): 81 doi: 10.1016/j.crohns.2010.12.006
|
| 26 |
Nancy Benight, Douglas G. Burrin, Barbara Stoll. Glutathione and Sulfur Amino Acids in Human Health and Disease. 2009; : 47 doi: 10.1002/9780470475973.ch4
|
| 27 |
Jeeshan Chowdhury, Govind V. Kagiala, Sudeep Pushpakom, Jana Lauzon, Alistair Makin, Alexey Atrazhev, Alex Stickel, William G. Newman, Christopher J. Backhouse, Linda M. Pilarski. Microfluidic Platform for Single Nucleotide Polymorphism Genotyping of the Thiopurine S-Methyltransferase Gene to Evaluate Risk for Adverse Drug Events. The Journal of Molecular Diagnostics 2007; 9(4): 521 doi: 10.2353/jmoldx.2007.070014
|
| 28 |
Roberto Catanzaro, Francesco Marotta, Azam Yazdani, Morena Sciuto. Inflammatory Bowel Disease Therapies and Acute Liver Injury. Toxics 2024; 12(6): 421 doi: 10.3390/toxics12060421
|
| 29 |
Jayshri A. Shah, Cathryn M. Edwards, Chris S. Probert. Should azathioprine and 5-aminosalicylates be coprescribed in inflammatory bowel disease?: an audit of adverse events and outcome. European Journal of Gastroenterology & Hepatology 2008; 20(3): 169 doi: 10.1097/MEG.0b013e3282f16d50
|
| 30 |
S. Bonnet Ducrot, D. Plantaz, N. Mathieu, T. Debillon, C. Bost Bru, M.-P. Brenier-Pinchart, H. Fricker-Hidalgo, M. Chevallier. Neonatal fever: A puzzling case. Archives de Pédiatrie 2018; 25(7): 435 doi: 10.1016/j.arcped.2018.08.004
|
| 31 |
|
| 32 |
Waseem Younis Khan, Farhat Jabeen, Nuzhat Khursheed, Bashir Ahmad Malla, Aarif Ali, Showkat Ahmad Ganie. Pharmacogenomics. 2023; : 271 doi: 10.1016/B978-0-443-15336-5.00011-7
|
| 33 |
Johan Van Limbergen, Richard K. Russell, Elaine R. Nimmo, Jack Satsangi. The Genetics of Inflammatory Bowel Disease. The American Journal of Gastroenterology 2007; 102(12): 2820 doi: 10.1111/j.1572-0241.2007.01527.x
|
| 34 |
|
| 35 |
Amosy E. M'Koma, Paul E. Wise, David A. Schwartz, Roberta L. Muldoon, Alan J. Herline. Prevalence and Outcome of Anemia After Restorative Proctocolectomy. Diseases of the Colon & Rectum 2009; 52(4): 726 doi: 10.1007/DCR.0b013e31819ed571
|
| 36 |
Victoria A. Joshi, Raju Kucherlapati. Genetics and Genomics in the Practice of Medicine. Gastroenterology 2008; 134(5): 1284 doi: 10.1053/j.gastro.2008.03.046
|
| 37 |
Yang Wang, Yimin Li, Yun Liu, Yifan Zhang, Ziliang Ke, Yu Zhang, Yulan Liu. Patients With IBD Receiving Methotrexate Are at Higher Risk of Liver Injury Compared With Patients With Non-IBD Diseases: A Meta-Analysis and Systematic Review. Frontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.774824
|
| 38 |
Paraskevi Nani, Melpomeni Ladopoulou, Evgenia H. Papaioannou, Evangelia D. Papagianni, Charalabos Antonatos, Panagiotis Xiropotamos, Andreas Kapsoritakis, Petros S. Potamianos, Konstantinos Karmiris, Charalambos Tzathas, Aikaterini Patsatsi, Elisavet Lazaridou, Efterpi Zafiriou, Angeliki Roussaki-Schulze, Sophia Georgiou, Katerina Grafanaki, Georgios K. Georgakilas, Yiannis Vasilopoulos. Pharmacogenetic Analysis of the MIR146A rs2910164 and MIR155 rs767649 Polymorphisms and Response to Anti-TNF Treatment in Patients with Crohn’s Disease and Psoriasis. Genes 2023; 14(2): 445 doi: 10.3390/genes14020445
|